Abt Global Inc. in Rockville said in a Work Adjustment and Training Notification with the Maryland Department of Labor that it is laying off 241 employees in the state, effective April 1.

New Delhi: Tamarind Global, a homegrown destination management company, has launched a brand-new logo as part of its transformative brand revamp. More than just a visual update, the new logo ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal ...

A new research paper was published by Aging (Aging-US) on December 3, 2024, in Volume 17, Issue 1, titled "Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing.

The extra power is accompanied by several carbon fiber parts and aero enhancements. ABT has also worked its magic on the RS Q8’s advanced suspension. The Audi RS Q8 may not have the same appeal ...

Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1. ...

Rockville’s Abt Global Inc., which has hundreds of millions of dollars in contracts with USAID, will lay off 241 employees, it said last week. Bethesda’s DAI Global furloughed nearly 400 ...

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The company’s shares opened today at $129.75.

Held every four years, the Global Refugee Forum is the world’s largest international gathering on refugees. It brings together UN Member States, non-governmental organizations, the private sector, ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.